Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · IEX Real-Time Price · USD
2.740
0.00 (0.00%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Heron Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
127.04107.6786.3588.64145.9777.4730.771.2800
Upgrade
Revenue Growth (YoY)
17.99%24.70%-2.59%-39.28%88.41%151.81%2305.55%---
Upgrade
Cost of Revenue
65.1154.8746.0236.1961.6227.514.590.0400
Upgrade
Gross Profit
61.9452.840.3352.4584.3549.9626.181.2400
Upgrade
Selling, General & Admin
116.66119.95127.33106.08127.6693.8782.1669.0335.7419.73
Upgrade
Research & Development
55.9107.51130.82174.53167.38140.03138.58103.1361.1854.83
Upgrade
Other Operating Expenses
000.8800000-0.120.92
Upgrade
Operating Expenses
172.55227.46259.03280.61295.04233.9220.74172.1696.8175.48
Upgrade
Operating Income
-110.62-174.66-218.71-228.16-210.69-183.94-194.56-170.92-96.81-75.48
Upgrade
Interest Expense / Income
0.50.841.98-1.73-5.79-3.292.892.220.780.89
Upgrade
Other Expense / Income
-0.566.53-0.85-0.16-1.80.040.01--
Upgrade
Pretax Income
-110.56-182.02-220.68-227.28-204.75-178.84-197.48-173.14-97.59-76.37
Upgrade
Net Income
-110.56-182.02-220.68-227.28-204.75-178.84-197.48-173.14-97.59-76.37
Upgrade
Shares Outstanding (Basic)
1381099891827354383327
Upgrade
Shares Outstanding (Diluted)
1381099891827354383327
Upgrade
Shares Change
26.87%10.57%8.48%11.00%11.73%35.44%42.49%14.64%24.51%64.38%
Upgrade
EPS (Basic)
-0.80-1.67-2.24-2.50-2.50-2.44-3.65-4.56-2.95-2.87
Upgrade
EPS (Diluted)
-0.80-1.67-2.24-2.50-2.50-2.44-3.65-4.56-2.95-2.87
Upgrade
Free Cash Flow
-60.32-148.51-206.34-191.63-131.73-200.95-172.78-137.23-79.37-61.72
Upgrade
Free Cash Flow Per Share
-0.44-1.36-2.10-2.11-1.61-2.75-3.20-3.62-2.40-2.32
Upgrade
Gross Margin
48.75%49.04%46.70%59.17%57.79%64.49%85.09%97.26%--
Upgrade
Operating Margin
-87.07%-162.21%-253.29%-257.41%-144.34%-237.42%-632.36%-13363.17%--
Upgrade
Profit Margin
-87.02%-169.05%-255.58%-256.41%-140.27%-230.84%-641.87%-13537.37%--
Upgrade
Free Cash Flow Margin
-47.48%-137.93%-238.97%-216.20%-90.25%-259.38%-561.56%-10729.63%--
Upgrade
EBITDA
-107.16-178.3-215.69-226.16-208.49-180.62-193.07-169.83-96.07-74.9
Upgrade
EBITDA Margin
-84.35%-165.59%-249.79%-255.15%-142.83%-233.14%-627.51%-13277.95%--
Upgrade
Depreciation & Amortization
2.92.893.022.852.041.511.531.10.730.58
Upgrade
EBIT
-110.06-181.19-218.71-229.01-210.54-182.13-194.6-170.92-96.81-75.48
Upgrade
EBIT Margin
-86.63%-168.28%-253.29%-258.37%-144.23%-235.09%-632.48%-13363.88%--
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).